ESI收录期刊
|
|
| 按影响因子排序： 升 | 降 | 第37页 首页 上一页 下一页 末页 共有763条记录 |
| 序号 | ESI刊名缩写 | 期刊名称 | ISSN | 影响因子(2023) |
收录数据库：JCR学科(分区) |
| 721 | EXP PSYCHOL | EXPERIMENTAL PSYCHOLOGY | 16183169 | 1.1 | SSCI:PSYCHOLOGY, EXPERIMENTAL(Q4) |
| 722 | EXP TECHNIQUES | EXPERIMENTAL TECHNIQUES | 07328818 | 1.5 | SCIE:ENGINEERING, MECHANICAL(Q3) SCIE:MATERIALS SCIENCE, CHARACTERIZATION & TESTING(Q3) SCIE:MECHANICS(Q3) |
| 723 | EXP THERM FLUID SCI | EXPERIMENTAL THERMAL AND FLUID SCIENCE | 08941777 | 2.8 | SCIE:ENGINEERING, MECHANICAL(Q2) SCIE:PHYSICS, FLUIDS & PLASMAS(Q1) SCIE:THERMODYNAMICS(Q2) |
| 724 | EXP FLUIDS | EXPERIMENTS IN FLUIDS | 07234864 | 2.3 | SCIE:ENGINEERING, MECHANICAL(Q2) SCIE:MECHANICS(Q2) |
| 725 | EXPERT OPIN BIOL TH | EXPERT OPINION ON BIOLOGICAL THERAPY | 14712598 | 3.6 | SCIE:BIOTECHNOLOGY & APPLIED MICROBIOLOGY(Q2) SCIE:MEDICINE, RESEARCH & EXPERIMENTAL(Q2) |
| 726 | EXPERT OPIN DRUG DEL | EXPERT OPINION ON DRUG DELIVERY | 17425247 | 5.0 | SCIE:PHARMACOLOGY & PHARMACY(Q1) |
| 727 | EXPERT OPIN DRUG DIS | EXPERT OPINION ON DRUG DISCOVERY | 17460441 | 6.0 | SCIE:PHARMACOLOGY & PHARMACY(Q1) |
| 728 | EXPERT OPIN DRUG MET | EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | 17425255 | 3.9 | SCIE:BIOCHEMISTRY & MOLECULAR BIOLOGY(Q2) SCIE:PHARMACOLOGY & PHARMACY(Q1) SCIE:TOXICOLOGY(Q1) |
| 729 | EXPERT OPIN DRUG SAF | EXPERT OPINION ON DRUG SAFETY | 14740338 | 3.0 | SCIE:PHARMACOLOGY & PHARMACY(Q2) |
| 730 | EXPERT OPIN EMERG DR | EXPERT OPINION ON EMERGING DRUGS | 14728214 | 2.7 | SCIE:PHARMACOLOGY & PHARMACY(Q2) |
| 731 | EXPERT OPIN INV DRUG | EXPERT OPINION ON INVESTIGATIONAL DRUGS | 13543784 | 4.9 | SCIE:PHARMACOLOGY & PHARMACY(Q1) |
| 732 | EXPERT OPIN PHARMACO | EXPERT OPINION ON PHARMACOTHERAPY | 14656566 | 2.5 | SCIE:PHARMACOLOGY & PHARMACY(Q3) |
| 733 | EXPERT OPIN THER PAT | EXPERT OPINION ON THERAPEUTIC PATENTS | 13543776 | 5.4 | SCIE:CHEMISTRY, MEDICINAL(Q1) SCIE:PHARMACOLOGY & PHARMACY(Q1) |
| 734 | EXPERT OPIN THER TAR | EXPERT OPINION ON THERAPEUTIC TARGETS | 14728222 | 4.6 | SCIE:PHARMACOLOGY & PHARMACY(Q1) |
| 735 | EXPERT REV ANTICANC | EXPERT REVIEW OF ANTICANCER THERAPY | 14737140 | 2.9 | SCIE:ONCOLOGY(Q2) |
| 736 | EXPERT REV ANTI-INFE | EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 14787210 | 4.2 | SCIE:INFECTIOUS DISEASES(Q1) SCIE:MICROBIOLOGY(Q2) SCIE:PHARMACOLOGY & PHARMACY(Q1) |
| 737 | EXPERT REV CLIN IMMU | EXPERT REVIEW OF CLINICAL IMMUNOLOGY | 1744666X | 3.9 | SCIE:IMMUNOLOGY(Q2) |
| 738 | EXPERT REV CLIN PHAR | EXPERT REVIEW OF CLINICAL PHARMACOLOGY | 17512433 | 3.6 | SCIE:PHARMACOLOGY & PHARMACY(Q2) |
| 739 | EXPERT REV GASTROENT | EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY | 17474124 | 3.8 | SCIE:GASTROENTEROLOGY & HEPATOLOGY(Q2) |
| 740 | EXPERT REV HEMATOL | EXPERT REVIEW OF HEMATOLOGY | 17474086 | 2.3 | SCIE:HEMATOLOGY(Q2) |
| 按影响因子排序:升|降 | 第37页 首页 上一页 下一页 末页 共有763条记录 |